메뉴 건너뛰기
Diabetologie und Stoffwechsel
Volumn 3, Issue 4, 2008, Pages 229-233
Position statement of the German Diabetes Association (DDG) on the results of the ACCORD- and ADVANCE-studies;Stellungnahme der DDG zu den ergebnissen der ACCORD- und ADVANCE-studien
Author keywords

[No Author keywords available]
Indexed keywords

ACARBOSE; ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EXENDIN 4; GLICLAZIDE; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; SITAGLIPTIN;
EID: 55349127087     PISSN: 18619002     EISSN: 18619010     Source Type: Journal    
DOI: 10.1055/s-2008-1076913     Document Type: Editorial
Times cited : (1)
References (7)
  • 1
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type-2 diabetes. (UKPDS33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type-2 diabetes. (UKPDS33). Lancet 1998; 352: 837-853
    • (1998) Lancet , vol.352 , pp. 837-853
  • 2
    • 0034071036 scopus 로고    scopus 로고
    • Long-term results of the Kumamoto Study on optimal diabetes control in type2 diabetic patients
    • Shichiri M, Kishikawa H, Ohkubo Y et al. Long-term results of the Kumamoto Study on optimal diabetes control in type2 diabetic patients. Diabetes Care 2000; 23 (Suppl.2): B21-B29
    • (2000) Diabetes Care , vol.23 , Issue.SUPPL.2
    • Shichiri, M.1    Kishikawa, H.2    Ohkubo, Y.3
  • 3
    • 45149131667 scopus 로고    scopus 로고
    • Effect of intensive glucose lowering in type2 diabetes
    • The Action to Control Cardiovascular Risk in Diabetes Study Group
    • The Action to Control Cardiovascular Risk in Diabetes Study Group. Effect of intensive glucose lowering in type2 diabetes. N Eng J Med 2008; 358: 2545-2559
    • (2008) N Eng J Med , vol.358 , pp. 2545-2559
  • 4
    • 45149133036 scopus 로고    scopus 로고
    • Intensive blood glucose control and vascular outcomes in patients with type2 diabetes
    • The ADVANCE Collaborative Group
    • The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type2 diabetes. N Eng J Med 2008; 358: 2560-2572
    • (2008) N Eng J Med , vol.358 , pp. 2560-2572
  • 5
    • 34548420712 scopus 로고    scopus 로고
    • The ADVANCE Collaborative Group. Effect of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type2 diabetes mellitus
    • Patel A, McMahon S et al., The ADVANCE Collaborative Group. Effect of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type2 diabetes mellitus. Lancet 2007; 370: 829-840
    • (2007) Lancet , vol.370 , pp. 829-840
    • Patel, A.1    McMahon, S.2
  • 6
    • 45149118855 scopus 로고    scopus 로고
    • Intensive glycemic control in the ACCORD and ADVANCE trials
    • Dluhy RG, McMahon GT. Intensive glycemic control in the ACCORD and ADVANCE trials. N Eng J Med 2008; 358: 2630-2633
    • (2008) N Eng J Med , vol.358 , pp. 2630-2633
    • Dluhy, R.G.1    McMahon, G.T.2
  • 7
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type2 diabetes (UKPDS34)
    • UKPDS Group
    • UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type2 diabetes (UKPDS34). Lancet 1998; 352: 854-865
    • (1998) Lancet , vol.352 , pp. 854-865

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.